About EQRx, Inc.


  • Ticker EQRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 448,140,992
  • Description
  • EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...
More about EQRX
Track This Portfolio

Track Ah Equity Partners Bio Ii, L.L.C. Portfolio

Follow Ah Equity Partners Bio Ii, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ah Equity Partners Bio Ii, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Ah Equity Partners Bio Ii, L.L.C. with notifications on news.